Get startedLog in
    Picture of Titan Biotech logo

    524717 — Titan Biotech Income Statement

    0.000.00%
    in flag iconLast trade - 00:00
    HealthcareHighly SpeculativeSmall CapHigh Flyer
    Balance sheetIncome statementCashflow
    Subscribe to view all data

    Annual income statement for Titan Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

    2021
    March 31st
    R2022
    March 31st
    2023
    March 31st
    2024
    March 31st
    2025
    March 31st
    Period Length:12 M12 M12 M12 M12 M
    Source:ARSARSARSARSARS
    Standards:
    IAS
    IAS
    IAS
    IAS
    IAS
    Status:FinalFinalFinalFinalFinal
    Revenue
    Total Revenue1,4221,2351,4401,6411,565
    Cost of Revenue
    Gross Profit777550606729697
    Selling / General / Administrative Expenses
    Depreciation and Amortization
    Unusual Expense / Income
    Other Operating Expenses
    Total Operating Expenses9869461,1711,3311,352
    Operating Profit436289269310213
    Gain / Loss on Sale of Assets
    Total Net Non Operating Interest Income / Expense
    Other Net Non Operating Costs
    Net Income Before Taxes427290281315244
    Provision for Income Taxes
    Net Income After Taxes317217210237183
    Minority Interest
    Equity in Affiliates
    Net Income Before Extraordinary Items
    Net Income303217248249215
    Income Available to Common Shareholders Excluding Extraordinary Items
    Income Available to Common Shareholders Including Extraordinary Items
    Diluted Net Income303217248249215
    Diluted Weighted Average Shares
    Basic EPS Including Extraordinary Items
    Diluted EPS Including Extraordinary Items
    Diluted EPS Excluding Extraordinary Items
    Normalised Income Before Taxes
    Normalised Income After Taxes
    Normalised Income Available to Common Shareholders
    Diluted Normalised EPS3726.230.130.126.1
    Dividends per Share